{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:24:55Z","timestamp":1707524695770},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,14]]},"DOI":"10.7759\/cureus.26848","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T15:05:59Z","timestamp":1657811159000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of and Current Trends in the Management of Gastrointestinal Stromal Tumors: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Hadia","family":"Arzoun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirra","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siji  S","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber","family":"Kuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Clinical presentation, diagnosis, and prognosis of gastrointestinal stromal tumors. (2021). Accessed. March 2, 2022: https:\/\/www.uptodate.com\/contents\/clinical-presentation-diagnosis-and-prognosis-of-gastrointestinal-stromal-tumors."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpge.2015.12.007","article-title":"Small bowel GIST: clinical presentation as intussusception and obscure bleeding","volume":"23","author":"Giestas S","year":"2016","unstructured":"Giestas S, Almeida N, Martins R, Canhoto A, Oliveira P, Figueiredo P, Sofia C. Small bowel GIST: clinical presentation as intussusception and obscure bleeding. GE Port J Gastroenterol. 2016, 23:279-81. 10.1016\/j.jpge.2015.12.007","journal-title":"GE Port J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00230","article-title":"Na+\/Ca2 + exchange and pacemaker activity of interstitial cells of Cajal","volume":"11","author":"Zheng H","year":"2020","unstructured":"Zheng H, Drumm BT, Zhu MH, et al.. Na+\/Ca2 + exchange and pacemaker activity of interstitial cells of Cajal. Front Physiol. 2020, 11:230. 10.3389\/fphys.2020.00230","journal-title":"Front Physiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4137\/BIC.S25045","article-title":"Gastrointestinal stromal tumors (GIST): a prospective analysis and an update on biomarkers and current treatment concepts","volume":"7","author":"Koumarianou A","year":"2015","unstructured":"Koumarianou A, Economopoulou P, Katsaounis P, et al.. Gastrointestinal stromal tumors (GIST): a prospective analysis and an update on biomarkers and current treatment concepts. Biomark Cancer. 2015, 7:1-7. 10.4137\/BIC.S25045","journal-title":"Biomark Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.5925","article-title":"CD117 expression is a predictive marker for poor prognosis in patients with non-small cell lung cancer","volume":"13","author":"Sakabe T","year":"2017","unstructured":"Sakabe T, Azumi J, Haruki T, Umekita Y, Nakamura H, Shiota G. CD117 expression is a predictive marker for poor prognosis in patients with non-small cell lung cancer. Oncol Lett. 2017, 13:3703-8. 10.3892\/ol.2017.5925","journal-title":"Oncol Lett"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-017-4533-y","article-title":"Stem cell factor\/KIT signal insufficiency contributes to hypoxia-induced intestinal motility dysfunctions in neonatal mice","volume":"62","author":"Ren H","year":"2017","unstructured":"Ren H, Han J, Li Z, Xiong Z. Stem cell factor\/KIT signal insufficiency contributes to hypoxia-induced intestinal motility dysfunctions in neonatal mice. Dig Dis Sci. 2017, 62:1193-203. 10.1007\/s10620-017-4533-y","journal-title":"Dig Dis Sci"},{"key":"ref7","unstructured":"National Library of Medicine. (2021). Accessed. March 2, 2022: https:\/\/medlineplus.gov\/download\/genetics\/gene\/kit.pdf."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2018.08.20","article-title":"Gastrointestinal stromal tumors: a comprehensive review","volume":"10","author":"Parab TM","year":"2019","unstructured":"Parab TM, DeRogatis MJ, Boaz AM, et al.. Gastrointestinal stromal tumors: a comprehensive review. J Gastrointest Oncol. 2019, 10:144-54. 10.21037\/jgo.2018.08.20","journal-title":"J Gastrointest Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S101385","article-title":"Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectives","volume":"9","author":"Mulet-Margalef N","year":"2016","unstructured":"Mulet-Margalef N, Garcia-Del-Muro X. Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectives. Onco Targets Ther. 2016, 9:7573-82. 10.2147\/OTT.S101385","journal-title":"Onco Targets Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S159689","article-title":"Management of hemorrhage in gastrointestinal stromal tumors: a review","volume":"10","author":"Liu Q","year":"2018","unstructured":"Liu Q, Kong F, Zhou J, Dong M, Dong Q. Management of hemorrhage in gastrointestinal stromal tumors: a review. Cancer Manag Res. 2018, 10:735-43. 10.2147\/CMAR.S159689","journal-title":"Cancer Manag Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0388-7","article-title":"Secondary KIT mutations: the GIST of drug resistance and sensitivity","volume":"120","author":"Napolitano A","year":"2019","unstructured":"Napolitano A, Vincenzi B. Secondary KIT mutations: the GIST of drug resistance and sensitivity. Br J Cancer. 2019, 120:577-8. 10.1038\/s41416-019-0388-7","journal-title":"Br J Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v8.i15.3142","article-title":"Recent advances in the management of gastrointestinal stromal tumor","volume":"8","author":"Ahmed M","year":"2020","unstructured":"Ahmed M. Recent advances in the management of gastrointestinal stromal tumor. World J Clin Cases. 2020, 8:3142-55. 10.12998\/wjcc.v8.i15.3142","journal-title":"World J Clin Cases"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-01026-6","article-title":"The management of metastatic GIST: current standard and investigational therapeutics","volume":"14","author":"Kelly CM","year":"2021","unstructured":"Kelly CM, Gutierrez Sainz L, Chi P. The management of metastatic GIST: current standard and investigational therapeutics. J Hematol Oncol. 2021, 14:2. 10.1186\/s13045-020-01026-6","journal-title":"J Hematol Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2017.12.006","article-title":"Systematic review of current prognostication systems for primary gastrointestinal stromal tumors","volume":"44","author":"Khoo CY","year":"2018","unstructured":"Khoo CY, Chai X, Quek R, Teo MC, Goh BK. Systematic review of current prognostication systems for primary gastrointestinal stromal tumors. Eur J Surg Oncol. 2018, 44:388-94. 10.1016\/j.ejso.2017.12.006","journal-title":"Eur J Surg Oncol"},{"key":"ref16","article-title":"Practical Soft Tissue Pathology: A Diagnostic Approach","author":"Hornick JL","unstructured":"Hornick JL. Practical Soft Tissue Pathology: A Diagnostic Approach. Hornick JL (ed): Elsevier, St. Louis;"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.4293","article-title":"Can individualized sunitinib dose and schedule changes optimize outcomes for kidney cancer patients?","volume":"10","author":"Bjarnason GA","year":"2016","unstructured":"Bjarnason GA. Can individualized sunitinib dose and schedule changes optimize outcomes for kidney cancer patients?. Can Urol Assoc J. 2016, 10:S252-5. 10.5489\/cuaj.4293","journal-title":"Can Urol Assoc J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/90689-evaluation-of-and-current-trends-in-the-management-of-gastrointestinal-stromal-tumors-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:29Z","timestamp":1707507869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/90689-evaluation-of-and-current-trends-in-the-management-of-gastrointestinal-stromal-tumors-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.26848","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,14]]}}}